Home » Newsletters » BioWorld Science

BioWorld Science

July 11, 2014

View Archived Issues

Novel S1P1 receptor ligands designed by Allergan

Scientists at Purdue Pharma divulge new opioid receptors ligands

Chinese companies disclose new PI3Kalpha inhibitors

Domainex reports promising preclinical data for lead compound in model of COPD

NIH funds phase II trial of NeuroSigma's eTNS System

Biosceptre raises funds for development of BIL-221-s

Insys Therapeutics completes human abuse study for dronabinol

CNX-013-B2, a pan-PPAR activator for diabetes and obesity

Biological characterization of a first-in-class, small-molecule, anticancer kinetochore inhibitor

Kyoto Pharmaceutical's PTP-1B inhibitor, a promising candidate for diabetes and obesity

Clinical results reported for TTP-399, a liver-selective GKA for type 2 diabetes

Beloranib granted orphan drug status in the E.U. for Prader-Willi syndrome

Evzio auto-injector available in the U.S. for emergency treatment of opioid overdose

Merck & Co. discloses new Mdm2 inhibitors

Sarepta Therapeutics reports long-term data from phase IIb study of eteplirsen

Quanticel prepares novel histone demethylase inhibitors

TransTech Pharma agrees with FDA on special protocol assessment for TTP-488

Givinostat shows activity in models of glioblastoma

MabVax Therapeutics and Telik finalize merger

Baxter acquires AesRx

NDA for Kythera Biopharmaceuticals' ATX-101 accepted

Glenmark initiates first-in-human trial of MPGES-1 inhibitor

Viamet reports new phase IIa data on VT-1161 in tinea pedis and acute vulvovaginal candidiasis

Bristol-Myers Squibb plans Q3 BLA for Opdivo in advanced melanoma

Takeda plans phase I study of ixazomib citrate in lupus nephritis

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 11, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...